Authors


Darian Daniel, PharmD Candidate

Latest:

Fourth-Year Pharmacy Students Help Patients and Practitioners in Transitional Care

Students are being exposed to new patient experiences through collaboration with practitioners.


Ralph J. Riello, PharmD, BCPS

Latest:

Hepatic Encephalopathy: Critical Insights and Closing Thoughts

In their concluding remarks, Arun Jesudian, MD; Ralph J. Riello, PharmD, BCPS, and Chas McCormick, RPh, MBA, summarize the key takeaways and highlight the persistent unmet needs in the management of hepatic encephalopathy.


Elleny Johnson, BS, PhT

Latest:

Automation Provides Pathway to Success

Technology clears the way to offer clinical-focused tasks, ultimately improving job satisfaction and minimizing burnout.


Reyaz Mussaleen, PharmD Candidate

Latest:

ADCs: The New Frontier in Cancer Treatment

Antibody-drug conjugates (ADCs) revolutionize cancer therapy by delivering powerful drugs directly to tumors and minimize damage to healthy cells.


Rose Denzer, PharmD, AAHIVP

Latest:

Interest Grows in Long-Acting Injectables for HIV Treatment

Continued advancements in therapy may expand its use to larger patient population, though challenges remain


Evan Shockey, PharmD candidate

Latest:

Navigating Paxlovid Interactions With Anticoagulants

Interactions between nirmatrelvir/ritonavir and direct oral anticoagulants is complicated, and a point of contrasting views between the US and EU medical communities.


Dana Krug

Latest:

Pharmacy of the Future: How Next Generation Solid State Cooling Opens the Last Mile and Ensures Drug Quality and Cold Chain Compliance

By embracing innovation in solid state cooling and proactively adapting to regulatory changes, pharmacies can improve patient access and compliance to medications, while taking advantage of additional revenue streams and proactively managing down costs.


Eugenia Kwon, PharmD Candidate

Latest:

In a Nod to Precision Oncology, the FDA Approves Revumenib

The approval marks a significant milestone in the treatment of a rare and aggressive subtype of acute leukemia.


Edmond M. Nunes, PharmD, RPh, BCSCP

Latest:

Clinical Overview: Isotretinoin (Absorica) for Severe Recalcitrant Nodular Acne

Isotretinoin exerts dose-dependent inhibition of sebaceous gland function, thereby reducing sebum secretion, which is associated with improvement in nodular acne.


Ashley Torres, MS; and Shane Desselle, RPh, PhD, FAPhA

Latest:

Tip of the Week: Managing Work-related Stress and Burnout

Pharmacists and pharmacy staff failing to deal adequately with stressors put themselves and their patients at risk through mounting frustration, tiredness, burnout, and commission of errors.


James Wheeler, PharmD, BCPS

Latest:

5 Tips for Graduating Pharmacy Students and Recent Graduates

Although the coronavirus disease 2019 (COVID-19) pandemic has raised unprecedented challenges, compounding already-tough competition for open positions, opportunities still exist.


Jonathan A. Keller, PharmD, JD; Megan Herber, MPH; Larissa Morgan, JD, MBE

Latest:

DEA’s Proposed Rules on Controlled Substances Prescribing via Telemedicine and Their Uncertain Impact on the Pharmacy Community

Proposed rules would permit a telehealth provider to prescribe only up to a 30-day supply of a Schedule III-V non-narcotic controlled substance or buprenorphine through telehealth without the patient first being evaluated in person by a provider.


D. Kelly Porter

Latest:

Florida Authorizes Use of Automated Dispensing Systems

New legislation allows community pharmacies to improve medication access in an outpatient setting.


Jae Shin, MD

Latest:

Bacteroidetes: The Jekyll and Hyde of the Human Gut Microbiome

The relative abundance of gram-negative Bacteroidetes to other phyla, such as gram-positive Firmicutes, is essential to maintain biodiversity and human gut health.


Wafa Samara, PharmD

Latest:

Wafa Samara, PharmD, Shares How Oncology Pharmacists Are Transforming Cancer Care at City of Hope

Wafa Samara, PharmD, vice president and chief pharmacy officer at City of Hope, highlights the vital role of oncology pharmacists at City of Hope in improving patient outcomes, conducting and leading research, and working as integral members of the multidisciplinary care team.



Nancy Yousry, St. John’s University Doctorate of Pharmacy Class of 2024

Latest:

Molecular Biology, Treatment, and Ongoing Global Management of Hepatitis

Prior to the development of vaccines and direct-acting antivirals, hepatitis infections were treated through methods of prevention.


Vincent Mendiola, MD

Latest:

USC ALL Induction Regimen Combined With Newer TKIs Is Safe, Effective for Patients With Ph+ Disease

Achieving MRD flow cytometry negativity is crucial in monitoring and predicting survival outcomes.


Craig Dolan, PharmD, MBA

Latest:

Hospital Pharmacies Must Innovate to Drive Financial Recovery

The pharmaceutical supply chain, while always central to health care, will play an even more crucial role as the pandemic continues to threaten the financial viability of hospitals and health systems, large and small.


John Green

Latest:

John Green: "Tuberculosis Anywhere Is a Threat to People Everywhere"

Tuberculosis is a long-standing global health issue that requires continued public health vigilance to prevent a resurgence of this preventable and curable disease.


Javier Pinilla-Ibarz, MD, PhD

Latest:

Managing AEs With BTK Inhibitors in CLL

Lisa Nodzon, PhD, ARNP, AOCNP; Katie Tobon, PharmD, BCOP; and Javier Pinilla-Ibarz, MD, PhD, share insight on strategies for the monitoring and management of BTK inhibitor–associated toxicities in CLL and review the importance of a multidisciplinary approach to treatment.


Deepika Khedekar, MPharm

Latest:

Nuclear Isotopes Could Help Address Challenges in Oncology Clinical Trials

The radiation emerging from these isotopes can be used in 2 different ways in cancer trials: imaging (detection of tumors) and therapy (destruction of tumors).


Annie Lambert, PharmD, BCSCP

Latest:

Evaluating Compounding Compliance Coming Out of the COVID-19 Fog

As pharmacists were pulled into patient-facing roles, many hospitals were forced to scale back or make adjustments in medication compounding practices.


Michelle Krey, PharmD Candidate

Latest:

Factor XI Inhibitors: The Future of Anticoagulation

Factor XI inhibitors show promise as a safer alternative to direct oral anticoagulants for preventing and treating thrombosis, offering similar efficacy with reduced bleeding risk.


Katy L. Garrett, PharmD, AAHIVP, BCIDP

Latest:

Updated Cardiovascular Guidelines for Individuals with HIV Expand Statin Eligibility

Medication therapy management reimbursement can be a driving factor to work toward statin implementation in this patient group.



Christina Crawford, PharmD

Latest:

When to Call, When to Counsel: Acetazolamide for Idiopathic Intracranial Hypertension

Idiopathic intracranial hypertension was previously considered a rare condition, however, its prevalence is increasing in parallel with obesity in patient populations.


Yasmin Sheikh

Latest:

The UK Became a Leader in the Cell Therapy Revolution, but a Lack of Ongoing Investment Could Change That

Advanced cell therapies are now saving the lives of people whose blood cancer would previously have been incurable. While the UK was quick to recognize the potential of these innovative therapies, patient access to these therapies may change without continued investment in the UK's cell therapy infrastructure.


Ilona Holcomb, PhD

Latest:

Comparative Oncology: Advances in Cancer Care from Pets to Humans

Dogs share a number of cancers with humans, including melanoma, non-Hodgkin lymphoma, leukemia, and osteosarcoma.


Marc Bonaca, MD, MPH, FACC

Latest:

Exploring the Vascular Benefits of Semaglutide in Peripheral Artery Disease

Marc Bonaca, MD, PHH, FACC discussed semaglutide’s potential benefits for non-diabetic patients with peripheral artery disease.